Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

Tomokazu Tamura, Jumpei Ito, Keiya Uriu, +82

Nature Communications

Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

Jumpei Ito, Rigel Suzuki, Keiya Uriu, +78

Nature Communications

Various Omicron SubvariantsGeneticsViral PathogenesisGenomicsPhylogenetic Analysis +19

The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J‐SSCG 2020)

Moritoki Egi, Hiroshi Ogura, Tomoaki Yatabe, +223

Acute Medicine & Surgery

Trauma ResuscitationJ-sscg 2020Hospital MedicineCritical Care MedicineClinical Epidemiology +18

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, +86

Nature Communications

Cell response analysis in SARS-CoV-2 infected bronchial organoids

Emi Sano, Tatsuya Suzuki, Rina Hashimoto, +17

Communications Biology

Basal CellsCell Response AnalysisRespiratory DiseasesImmunologyViral Pathogenesis +9

Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

Tomokazu Tamura, Daichi Yamasoba, Yoshitaka Oda, +70

Communications Biology

Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells

Rina Hashimoto, Ayaka Sakamoto, Sayaka Deguchi, +6

Molecular Therapy — Nucleic Acids

Usability of Polydimethylsiloxane-Based Microfluidic Devices in Pharmaceutical Research Using Human Hepatocytes

Sayaka Deguchi, Masahiro Tsuda, Kaori Kosugi, +11

ACS Biomaterials Science & Engineering

Virological characterization of the 2022 outbreak‐causing monkeypox virus using human keratinocytes and colon organoids

Yukio Watanabe, Izumi Kimura, Rina Hashimoto, +5

Journal of Medical Virology

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors

Akishige Ikegame, Shuji Ozaki, Daisuke Tsuji, +18

Leukemia

HistocompatibilityCancer ImmunosurveillancePluripotency-associated Transcription FactorsImmunologySmall Molecule Antibody +5